评估社区干预措施在高血压预防和控制方面的有效性:系统性审查和元分析
Saber Azami-Aghdash1, Nasrin Joudyian2, Sahar Jafari3
1Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
BMC public health
|October 2, 2025
概括
基于社区的干预措施有效降低血压. 这一系统性审查强调了它们在预防和控制高血压方面的重要性,并建议进一步开发和实施.
科学领域:
- 公共卫生 公共卫生
- 心血管健康 心血管健康
- 卫生干预研究 研究 研究 干预
背景情况:
- 预防和控制高血压是关键的公共卫生优先事项.
- 基于社区的干预措施是管理高血压的关键策略.
- 对这些干预措施的系统评估对于基于证据的实践至关重要.
研究的目的:
- 系统地审查和元分析基于社区的高血压预防和控制干预措施的有效性.
- 确定影响这些干预成功的因素.
主要方法:
- 在多个数据库 (PubMed,Scopus,Web of Science,Google Scholar) 和2000-2025年期间的其他来源进行全面的文献搜索.
- 包括68篇文章,对34项使用随机效应模型进行的研究进行了元分析.
- 评估干预的有效性,异质性和出版偏见.
主要成果:
- 基于社区的干预措施显示出显著的有效性,降低了7.26 mmHg的静缩血压和2.77 mmHg的静缩血压.
- 在低收入和中等收入国家,医疗保健中心,单组件设计和少重复的干预措施显示出更大的有效性.
- 患者的随访持续时间和干预频率并不能显著预测血压变化.
结论:
- 基于社区的干预措施在预防和控制高血压方面非常有效.
- 强烈建议继续开发和实施这些干预措施.
- 进一步的研究可能会探索超越持续时间和频率的最佳干预参数.
相关概念视频
Hypertension IV: Drug Therapy and Lifestyle Modifications
624
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
624
Hypertension V: Nursing Management
359
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
359
Hypertension III: Clinical Manifestations and Diagnostic Studies
471
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
Hypertension II: Pathophysiology
795
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321

